ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Pulmonary Disease

Top Pulmonary Disease Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHAEL PRITCHETT D.O.

Pulmonary Disease

3,408

$1.32M

508
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 57%

$387
Average prescription price

Avg: $178

MICHAEL WERT M.D.

Pulmonary Disease

3,202

$260K

409
316 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 57%

$81
Average prescription price

Avg: $178

MIKELL JARRATT M.D.

Pulmonary Disease

3,141

$361K

475
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 57%

$115
Average prescription price

Avg: $178

CLINTON YOUNG M.D.

Pulmonary Disease

3,131

$567K

466
385 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 57%

$181
Average prescription price

Avg: $178

PATRICK WRIGHT M.D.

Pulmonary Disease

3,072

$387K

342
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 57%

$126
Average prescription price

Avg: $178

STUART GARNER M.D.

Pulmonary Disease

2,859

$689K

254
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 57%

$241
Average prescription price

Avg: $178

CARL SMART M.D.

Pulmonary Disease

2,719

$1.41M

323
198 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$518
Average prescription price

Avg: $178

ROBERT WARD M.D.

Pulmonary Disease

2,573

$401K

351
263 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$156
Average prescription price

Avg: $178

MARK DONER MD

Pulmonary Disease

2,571

$299K

400
312 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 57%

$116
Average prescription price

Avg: $178

ASHISH SINGH MD

Pulmonary Disease

2,484

$306K

332
216 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 57%

$123
Average prescription price

Avg: $178

MARK HELLREICH M.D.

Pulmonary Disease

2,406

$372K

295
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 57%

$155
Average prescription price

Avg: $178

HARRY LIPHAM MD

Pulmonary Disease

2,384

$184K

220
186 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 57%

$77
Average prescription price

Avg: $178

PATRICK KELLY MD

Pulmonary Disease

2,380

$551K

358
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 57%

$232
Average prescription price

Avg: $178

DALTON DOVE M.D.

Pulmonary Disease

2,351

$178K

172
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 57%

$76
Average prescription price

Avg: $178

KEVIN WOLFE MD

Pulmonary Disease

2,280

$273K

365
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 57%

$120
Average prescription price

Avg: $178

LAURIE SNYDER MD

Pulmonary Disease

2,259

$573K

169
87 are 65+

9%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 57%

$254
Average prescription price

Avg: $178

LOIS CLARY M.D.

Pulmonary Disease

2,253

$449K

288
244 are 65+

4%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 57%

$199
Average prescription price

Avg: $178

DAVID HAYES M.D.

Pulmonary Disease

2,199

$371K

339
286 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 57%

$169
Average prescription price

Avg: $178

KENNY NALL MD

Pulmonary Disease

2,198

$245K

252
200 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 57%

$111
Average prescription price

Avg: $178

ALICE GRAY MD

Pulmonary Disease

2,168

$613K

197
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 57%

$283
Average prescription price

Avg: $178

SELWYN SPANGENTHAL M.D.

Pulmonary Disease

2,073

$403K

281
197 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 57%

$194
Average prescription price

Avg: $178

CHARLES CUMMINGS M.D.

Pulmonary Disease

2,071

$183K

110
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 57%

$88
Average prescription price

Avg: $178

EUSEBIO DESUYO M.D.

Pulmonary Disease

2,049

$332K

189
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 57%

$162
Average prescription price

Avg: $178

NILESH PATEL M.D.

Pulmonary Disease

2,044

$1.03M

263
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

68%
prescriptions for brand name drugs

Avg: 57%

$502
Average prescription price

Avg: $178

JOHN FOGARTY MD

Pulmonary Disease

2,043

$409K

284
204 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 57%

$200
Average prescription price

Avg: $178

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank